Table 2.
Summary of results from studies reporting anti-HCV prevalence in pregnant women and first-time blood donors
| Author, year | Country | Recruiting period | Population as reported | Age, mean (SD) | Sample size | Anti-HCV prevalence (%) (95% CI) | Risk of selection bias |
|---|---|---|---|---|---|---|---|
| Pregnant women | |||||||
| Orkin, 2016 [30] | UK | 2013 | Women who attended antenatal clinics during 2013 at 2 London hospitals | – | 1000 | 0.50 (0.06–0.94) | High risk |
| Cortina-Borja, 2016 [31] | UK | 1 April–30 June 2012 | Women delivering live-born infants in the North Thames region in England | – | 31467 | 0.10 (0.07–0.14) | Low risk |
| Kopilovic, 2015 [32] | Slovenia | 1999, 2003, 2009 and 2013 | Pregnant women | – | 31849 | 0.13 (0.09–0.17) | Low risk |
| Lembo, 2017 [33] | Italy | January 2010–December 2015 | Pregnant women consecutively admitted to the Division of Obstetrics and Gynaecology of the University Hospital of Messina, Italy | – | 5184 | 0.20 (−) | High risk |
| Walewska-Zielecka, 2016 [34] | Poland | 2004–2014 | Pregnant women in Poland | 33.4(7.9) | 42274 | 1.32 (−) | Low risk |
| Millbourn, 2017 [35] | Sweden |
October 2013–March 2015 and October 2013–February 2016 |
Every pregnant woman and her partner in Orebro county and in Southern part of Stockholm (288,000 and 300,000 inhabitants, respectively) | – | 21379 | 0.20* (−) | Low risk |
| Munoz-Gamez, 2016 [36] | Spain | January–October 2015 | Pregnant women in Spain | – | − | 0.55 (0.55–0.77) | Low risk |
| First-time blood donors | |||||||
| Velati, 2018 [37] | Italy | January 2009–December 2015 | Voluntary, unpaid first-time donors | – | 1934612 | 0.09 (0.08–0.09) | Low risk |
| Politis, 2018 [38] | Greece | 2010–2016 | Blood donor | – | − | 0.03 (−) | High risk |
*calculated based on available data